Page last updated: 2024-08-26

arsenic and vorinostat

arsenic has been researched along with vorinostat in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Liu, ZJ; Lu, N; Wang, N; Yan, Z1
Chang, SY; Chien, CW; Lee, PC; Lee, TC; Yao, JH1
Chen, Y; Guan, X; Li, F; Li, N; Li, X1

Other Studies

3 other study(ies) available for arsenic and vorinostat

ArticleYear
[Three different drug interaction mathematical models used to evaluate the cytotoxicity of SAHA and arsenic trioxide in combination].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:5

    Topics: Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Combinations; Drug Interactions; Humans; Hydroxamic Acids; Models, Chemical; Oxides; Vorinostat

2010
Enhanced suppression of tumor growth by concomitant treatment of human lung cancer cells with suberoylanilide hydroxamic acid and arsenic trioxide.
    Toxicology and applied pharmacology, 2011, Nov-15, Volume: 257, Issue:1

    Topics: Animals; Antineoplastic Agents; Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Carcinoma, Non-Small-Cell Lung; Cell Cycle; Cell Line, Tumor; Comet Assay; DNA Damage; Drug Synergism; Drug Therapy, Combination; Flow Cytometry; Humans; Hydroxamic Acids; Lung Neoplasms; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oxides; Vorinostat

2011
Chemosensitivity enhancement toward arsenic trioxide by inhibition of histone deacetylase in NB4 cell line.
    The Journal of international medical research, 2016, Volume: 44, Issue:4

    Topics: Apoptosis; Arsenic Trioxide; Arsenicals; Blotting, Western; Cell Line, Tumor; Cell Proliferation; Histone Deacetylase Inhibitors; Histone Deacetylases; Humans; Hydroxamic Acids; Oxides; Vorinostat

2016